Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NanoFlu vs Fluzone Quadrivalent in Older Adults
NCT04120194Phase 3Completed
- Sponsor
- Novavax
- Start
- Oct 2019
- Primary completion
- Oct 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Influenza B virus B/Maryland/15/2016 recombinant hemagglutinin antigen in influenza, sponsored by Novavax. Started Oct 2019; status: completed.
02
Drugs
Influenza B virus B/Maryland/15/2016 recombinant hemagglutinin antigen
03
Conditions
influenza
Beyond the preview
Go deeper on NCT04120194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04120194.